BUVARD: Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood Spot
Sponsor
University Hospital, Rouen (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05390424
Collaborator
(none)
500
1
1
15
33.3
Study Details
Study Description
Brief Summary
The aim of the study is to screen for hepatitis B, hepatitis C and AIDS viruses using a Dried Blood Spot in drug users
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Study Design
Study Type:
Interventional
Anticipated Enrollment
:
500 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood Spot
Anticipated Study Start Date
:
Jun 1, 2022
Anticipated Primary Completion Date
:
Sep 1, 2023
Anticipated Study Completion Date
:
Sep 1, 2023
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Drug user Drug users will be screened for Hepatitis C, Hepatitis B and AIDS using Dried Blood Spot for blood collection |
Diagnostic Test: Blood collection using Dried Blood Spot
Drug users will be screened for Hepatitis C, Hepatitis B and AIDS using Dried Blood Spot for blood collection
|
Outcome Measures
Primary Outcome Measures
- Number of person with an active hepatitis C infection [Day 1]
- Number of person with an active hepatitis B infection [Day 1]
- Number of person with an active AIDS infection [Day 1]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
Former or active intravenous and/or nasal drug user
-
Person on opiate substitution therapy
Exclusion Criteria:
- Person with known active viral infection(s)
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | CSAPA la Boussole | Rouen | France |
Sponsors and Collaborators
- University Hospital, Rouen
Investigators
- Principal Investigator: Ghassan RIACHI, MD, Rouen University Hospital
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
University Hospital, Rouen
ClinicalTrials.gov Identifier:
NCT05390424
Other Study ID Numbers:
- 2021/098/HP
First Posted:
May 25, 2022
Last Update Posted:
May 25, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Rouen
Additional relevant MeSH terms: